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Abstract
Background: Msx1 and Msx2, which belong to the highly conserved Nk family of homeobox genes,
display overlapping expression patterns and redundant functions in multiple tissues and organs
during vertebrate development. Msx1  and  Msx2  have well-documented roles in mediating
epithelial-mesenchymal interactions during organogenesis. Given that both Msx1 and Msx2 are
crucial downstream effectors of Bmp signaling, we investigated whether Msx1  and  Msx2  are
required for the Bmp-induced endothelial-mesenchymal transformation (EMT) during
atrioventricular (AV) valve formation.
Results: While both Msx1-/- and Msx2-/- single homozygous mutant mice exhibited normal valve
formation, we observed hypoplastic AV cushions and malformed AV valves in Msx1-/-; Msx2-/-
mutants, indicating redundant functions of Msx1 and Msx2 during AV valve morphogenesis. In
Msx1/2 null mutant AV cushions, we found decreased Bmp2/4 and Notch1 signaling as well as
reduced expression of Has2, NFATc1 and Notch1, demonstrating impaired endocardial activation
and EMT. Moreover, perturbed expression of chamber-specific genes Anf, Tbx2, Hand1 and Hand2
reveals mispatterning of the Msx1/2 double mutant myocardium and suggests functions of Msx1 and
Msx2  in regulating myocardial signals required for remodelling AV valves and maintaining an
undifferentiated state of the AV myocardium.
Conclusion: Our findings demonstrate redundant roles of Msx1 and Msx2 in regulating signals
required for development of the AV myocardium and formation of the AV valves.
Background
A complex series of morphogenetic events and hemody-
namic influences are required for cardiogenesis [1-3].
Malformations of cardiac valves constitute the most prev-
alent form of human birth defects, appearing in nearly
one percent of newborn infants [4,5]. The formation of
cardiac valves requires two major consecutive steps: car-
diac cushion formation and valve remodeling [1,4,6].
After cardiac looping, the cardiac cushions in the regions
of the atrioventricular (AV) canal and distal outflow tract
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(OFT) are formed through an endothelial-mesenchymal
transformation (EMT), a remarkably complex event initi-
ated by the specification and activation of a subset of
endothelial cells in the cushion-forming regions. This
event is followed by cell delamination from the endocar-
dium and cell migration into the extracellular matrix
between the endocardium and myocardium (referred to
as the cardiac jelly) [4-6]. Concomitant with migration
into the cardiac jelly, the endothelial cells transdifferenti-
ate into mesenchymal cells and proliferate to form multi-
ple layers, resulting in the expansion of the cushion crests
toward each other [6]. AV cushion formation is followed
by a series of morphogenetic events, including elongation,
outgrowth and remodeling, which result in the conver-
sion of the thick cushions into thin valve leaflets [1,6-8].
Several signaling molecules have been implicated in regu-
lating EMT during cardiac valve formation, including the
Nuclear Factor in Activated T cells (NFAT) [9-12], Vascular
Endothelial Growth Factor (VEGF) [11,13], and members
of the Epidermal Growth Factor (EGF) [1,6,14,15], Bone
Morphogenetic Protein (Bmp) [16-19], Notch [20-22],
Transforming Growth Factor-β (TGF-β) [4,18,19,23], and
Wnt/β-catenin families [24,25].
Msx1 and Msx2, closely related members of the Nk-family
of homeobox transcription factors, have well-docu-
mented roles as both downstream effectors and upstream
regulators of Bmp signalling [26-29]. Msx1  and  Msx2
function redundantly in multiple tissues and organs dur-
ing vertebrate development, including the heart [30,31].
We showed previously that Msx1-/-; Msx2-/- mutants
exhibit malalignment defects of the developing outflow
tract including double outlet right ventricle and pulmo-
nary atresia or stenosis [30,32]. These defects are associ-
ated with excessive proliferation of cardiac neural crest,
endothelial and myocardial cells in the mutant outflow
tract between E10 and E11 [32].
Reduced expression of Msx1 and Msx2 was observed in the
AV cushions deficient in Bmp signaling. Such cushions
also displayed immature cardiac jelly, compromised AV
myocardium and hypoplastic AV valves [17,33]. How-
ever, no valve defects have been reported in mice deficient
in either Msx1 or Msx2 [34,35].
In the present study, we focused on AV cushion and valve
formation in mice with combined deficiencies of Msx1
and Msx2, and compared marker gene expression in Msx1-
/-; Msx2-/- double mutant AV cushions with that in Msx1-
/- and Msx2-/- single mutant AV cushions. We observed
hypoplastic AV cushions and deformed AV valves in Msx1-
/-; Msx2-/- double mutants but not in Msx1-/- or Msx2-/-
single mutants, and no discernable difference in the
expression of AV cushion markers between wild-type and
single mutant mice. On the other hand, there was a
reduced level of NFATc1 immunostaining in the Msx1/2
double mutant AV endocardium, and decreased expres-
sion of α-smooth muscle actin, Notch1, Has2, Bmp2/4 and
Pitx2 in the Msx1/2 double mutant AV cushion mesen-
chyme, indicating impaired EMT and cushion formation
[4,9,10,12,16,17,21,22,36-41]. In addition, perturbed
expression of Bmp2/4, Tbx2, Anf, Hand1 and Hand2 in the
Msx1/2 null mutant AV myocardium suggests impaired
myocardial patterning during chamber formation [17,42-
49]. Taken together, we conclude that Msx1  and  Msx2
function redundantly in regulating the expression of
genes required for AV canal (AVC) morphogenesis.
Results
Hypoplastic AV cushions and impaired endocardial 
signaling in Msx1-/-; Msx2-/- mutant hearts
Histological sections of hearts between E14.5 and E16.5
revealed atrial septal defect as well as deformed AV cush-
ions and valves in Msx1-/-; Msx2-/- double mutants (n =
8), but not in Msx1-/- or Msx2-/- single mutants (n = 22),
nor in Msx1-Msx2 homozygous-heterozygous compound
mutants (n = 20). All eight Msx1/2 null mutants examined
had hypoplastic AV cushions and shorter but thickened
AV valves, indicating a failure to undergo proper valve
outgrowth and remodeling (Fig. 1B, C, E and 1F).
To evaluate the functional redundancy of Msx1 and Msx2
in AV cushion morphogenesis, we examined expression
patterns of Msx1 and Msx2 in the AV canal (AVC) between
E9.5 and E11.5, while EMT of the endocardial cushions
was actively taking place [4,16,18]. At E9.5 and E10.5,
Msx1 and Msx2 displayed overlapping expression in the
endocardial and cushion mesenchymal cells, while Msx2
was also expressed in the AV myocardium, where no Msx1
expression was detected (Fig. 2A–D). By E11.5, Msx1
expression extended to the lateral cushion mesenchyme
adjacent to the AV myocardium as well as the membra-
nous parts of the interatrial and interventricular septa
(Fig. 2E). Our observations suggest that Msx1 and Msx2
may function redundantly during AV endocardial EMT
and AV cushion morphogenesis.
We then studied whether endocardial cell maturation and
activation were perturbed in Msx1/2  double mutants.
Immunostaining for NFATc1 (nuclear factor in activated T
cells), which was previously shown to be upregulated in
activated endothelial cells within the AVC [10,12,17],
indicated that NFATc1 was present in the Msx1/2 double
mutant AV endocardium at E10.5, but with a significantly
lower staining intensity compared to the control AV endo-
cardium (compare the regions pointed by red arrows in
Fig. 3A and 3B). In contrast, the intensity of NFATc1
immunostaining in the OFT endocardium was compara-
ble between controls and Msx1-/-; Msx2-/- mutants (com-
pare the regions indicated by red asterisks in Fig. 3A andBMC Developmental Biology 2008, 8:75 http://www.biomedcentral.com/1471-213X/8/75
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3B). At the same developmental stage, the expression of
Notch1, an essential inducer of EMT [4,21,22], was greatly
diminished in the Msx1/2  double mutant AV cushions
compared with the control (compare the regions pointed
by red arrows in Fig. 3C and 3D). In contrast, Notch1
expression in the Msx1/2 double mutant OFT cushions
was comparable with that in the control OFT (compare
the regions marked by red asterisks in Fig. 3C and 3D). On
the other hand, the expression of another endocardial
marker gene Twist1 in Msx1-/-; Msx2-/- double mutants
was comparable with that in control embryos (data not
shown).
We also analysed expression of Has2, which is the princi-
ple synthase of the extracellular matrix component
hyaluronan (HA) [1,36], in the AV cushion mesenchyme
of the Msx1-/-; Msx2-/- mutants. HA has been demon-
strated to mediate endocardial cushion expansion by
interacting with water and other extracellular matrix com-
ponents to create a hydrated low-resistance macromolecu-
lar environment that promotes loss of cell contact
inhibition and increased cell motility, which is a prerequi-
site of cardiac cushion expansion and subsequent EMT
[1,36,50-52]. Our results indicated normal expression of
Has2  in spite of a greatly decreased number of Has2-
expressing cells in the Msx1/2 double mutant AV cushion
mesenchyme (compare the regions pointed by red arrows
in Fig. 3E and 3F). Statistical analyses of multiple sections
across the AV cushions revealed that, in spite of normal
cell proliferation and apoptosis, there was a significant
reduction in the total number of mesenchymal cells in
Msx1-/-; Msx2-/- mutants compared with their littermate
controls (Fig. 4 and data not shown). In addition, we
found that there were only sparse mesenchymal cells
expressing α-smooth muscle actin (α-SMA) in the Msx1/2
Expression of Msx1 and Msx2 in the developing AV canal Figure 2
Expression of Msx1 and Msx2 in the developing AV 
canal. Section in situ hybridization showed that the domains 
of Msx1 and Msx2 expression overlap in a subpopulation of 
endocardial and cushion mesenchymal cells during AV cush-
ion morphogenesis between E9.5 and E11.5 (A-F). Msx2 also 
displayed strong expression in the myocardium of the AV 
canal and right ventricle at all developmental stages examined 
(B, D and F). Red asterisks indicate AV cushions. endo, endo-
cardium; FG, foregut; IAS and IVS, interatrial and interven-
tricular septum; LA and LV, left atrium and ventricle; myo, 
myocardium; RA and RV, right atrium and ventricle. Scale 
bars: 0.1 mm in A (for A, B), 0.2 mm in C (for C, D) and E 
(for E, F).
Hypoplastic AV cushions and disorganized AV valves in Msx1- /-; Msx2-/- double mutants at E15.5 Figure 1
Hypoplastic AV cushions and disorganized AV valves 
in Msx1-/-; Msx2-/- double mutants at E15.5. Panels D-F 
are enlarged views of the boxes in panels A-C from histolog-
ical sections of E15.5 embryonic hearts. Compared with the 
control (D), Msx1/2 null mutants have compromised AV 
cushions (indicated by white asterisks in the control and red 
asterisks in Msx1/2 double mutants), shorter and deformed 
AV valves extending from the cushions (indicated by triangle 
arrowheads in panels E and F), and hyperplastic AV valves 
extending from the AV myocardium (indicated by arrows in 
panels E and F), suggesting impaired valve outgrowth and 
remodeling following deficient EMT to form the AV cushions. 
The red arrow indicates atrial septal defect. IVS, interven-
tricular septum; LA and LV, left atrium and ventricle; RA and 
RV, right atrium and ventricle. Scale bars: 0.5 mm in A (for A-
C) and 0.2 mm in D, and F (for E, F).BMC Developmental Biology 2008, 8:75 http://www.biomedcentral.com/1471-213X/8/75
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double mutant AV cushions, whereas the majority of mes-
enchymal cells in the control AV cushions are α-SMA-pos-
itive (compare the regions indicated by red asterisks in
Fig. 4C, 4D, 4G and 4H). As α-SMA was previously shown
to be a marker of EMT [39], our results further support
impaired EMT in the Msx1/2 null mutant AV cushions,
which may contribute to a decreased total number of
cushion mesenchymal cells.
Loss of function of both Msx1 and Msx2 perturbs 
myocardial signaling in the AV canal
A variety of Bmps (bone morphogenetic proteins), includ-
ing Bmp2, Bmp4, Bmp5, Bmp6 and Bmp7, have been
implicated in regulating EMT during OFT and AV valve
formation [16-18,33,40,41,53,54]. As Msx1  and  Msx2
both have been shown to be upstream regulators of Bmp2,
Bmp4  and  Bmp7  during organogenesis [30,55-57], we
asked whether the EMT-regulating Bmp signals were defi-
cient in Msx1/2 mutant AV cushions. Immunostaining for
Bmp2/4 and phosphorylated Smad1/5/8 at E10.5 and
E11.5 revealed significantly decreased Bmp2/4 signaling
(more than 50% decrease at E10.5 and more than 30%
decrease at E11.5) in the AV cushion mesenchyme of
Msx1-/-; Msx2-/- mutants compared with their littermate
controls (Fig. 5E–H, 5M–P, 5Q and 5R; AV cushions are
marked by red and yellow asterisks). In addition to the AV
cushions, we also found decreased Bmp2/4 signaling in
the atrial and ventricular myocardium of Msx1/2 double
mutants (indicated by white triangle arrowheads in Fig.
5A–D and 5I–L). Therefore, in contrast to the local upreg-
ulation of Bmp2/4 signaling in the Msx1/2 null mutant
OFT and pharyngeal mesoderm (white arrows in Fig. 5A–
D, and our previous study) [32], down-regulation of
Bmp2/4 signaling in Msx1/2 double mutants is restricted
to the AV cushions and chamber myocardium.
Previous studies have demonstrated that Bmp2 induces
Tbx2 (T-box transcription factor 2) expression in the AV
myocardium, which in turn inhibits the expression of
chamber-specific genes including Anf  (atrial natriuretic
factor), Chisel and Cx40 in the AVC, and thus establishes
the identity of chamber myocardium [17,40,42,43,49]. To
investigate whether reduced Bmp2/4 signaling in Msx1/2
mutant AVC perturbed gene expression in the AV myocar-
dium, we compared expression of Tbx2 and Anf in con-
trols and Msx1/2  double mutants. In Msx1-/-; Msx2-/-
mutants, Tbx2 expression was dramatically reduced in the
AV myocardium (compare the regions pointed by red
arrowheads in Fig. 6A and 6B). This is a local down-regu-
lation, as Tbx2 expression in the pharyngeal mesoderm
was comparable between controls and Msx1/2  double
mutants (compare the regions pointed by black arrows in
Fig. 6A and 6B). In agreement with decreased Tbx2 expres-
sion,  Msx1/2  double mutants displayed increased and
ectopic expression of Anf in the AV myocardium (com-
pare the regions pointed by red arrowheads in Fig. 6C and
6D). Anf  expression was also increased in the myocar-
dium of the double mutant right ventricle (marked by the
red asterisk in Fig. 6D).
In addition to Tbx2, other transcription factors that have
been implicated in regulation of Anf expression, including
Hand1 [46], Hand2 [47], and Pitx2 [58], also exhibited
dramatically reduced expression in Msx1-/-; Msx2-/-
Impaired expression of endocardial and cushion mesenchy- mal genes in Msx1-/-; Msx2-/- mutant AV cushions Figure 3
Impaired expression of endocardial and cushion mes-
enchymal genes in Msx1-/-; Msx2-/- mutant AV cush-
ions. At E10.5, the immunostaining intensity of NFATc1 was 
reduced in Msx1-/-; Msx2-/- mutant AV endocardium com-
pared with the littermate control (red arrows in A, B), while 
the intensity was comparable between control and Msx1/2 
double mutant OFT endocardium (red asterisks in A, B). At 
the same developmental stage, RNA section in situ hybridiza-
tion revealed greatly diminished expression of Notch1 
(arrows in C, D) in the Msx1/2 double mutant AV cushion 
mesenchyme and endocardium compared with the control. 
In contrast, Notch1 expression was normal in the Msx1/2 
mutant OFT cushions (compare red asterisks in C and D). 
Note also a decreased number of Has2-expressing cells in 
the Msx1/2 null mutant AV cushion mesenchyme (red arrows 
in E, F). endo, endocardium; LA and LV, left atrium and ven-
tricle; mes, mesenchyme; RA and RV, right atrium and ventri-
cle. Scale bars: 0.1 mm in B (for A-D), 0.2 mm in F (for E, F).BMC Developmental Biology 2008, 8:75 http://www.biomedcentral.com/1471-213X/8/75
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mutant AVC (Fig. 6E–H and Fig. 7). Hand1 is normally
expressed in the left AV myocardium [45,48,59], but this
was almost undetectable in Msx1/2 double mutants (com-
pare the regions pointed by red arrows in Fig. 6E and 6F).
In addition, Hand1 expression was significantly decreased
in the left ventricular myocardium of the Msx1/2  null
mutants compared with the controls (marked by a red
asterisk in Fig. 6F; three pairs of Msx1-/-; Msx2-/- mutants
and littermate controls were analysed). Similar to Hand1,
there was an overall decrease of Hand2 expression in the
Msx1/2  double mutant myocardium (compare Fig. 6G
and 6H). In fact, we have previously demonstrated
reduced Hand1 and Hand2 expression in the Msx1/2 null
mutant OFT and secondary heart field, suggesting that
Hand1 and Hand2 are target genes regulated by Msx1 and
Msx2 [32]. We found that, in contrast to the control AV
cushions, where approximately 40–60% of mesenchymal
cells expressed Pitx2 (Fig. 7C, 7G and 7I; AV cushions are
marked by yellow asterisks), there were only sparse Pitx2-
expressing mesenchymal cells (average %10%) in the
Msx1/2 double mutant AV cushions (Fig. 7D, 7H and 7I).
In addition, there was a substantial reduction of Pitx2
immunostaining signal in the myocardium of the Msx1/2
double mutant left atrium shown in Fig. 7B and 7F (indi-
cated by white arrows; compare with Fig. 6A and 6E). Mul-
tiple lines of evidence have shown that loss of Hand1 or
Pitx2  expression in the AVC cause AV valve defects
[37,38,45,60]. Myocardium-specific deficiency of Hand1
was shown to cause hyperplastic AV cushions and thick-
ened AV valves [45], implicating Hand1 in post EMT valve
remodelling [6]. Pitx2 may be required for both EMT and
post EMT cushion morphogenesis, as Pitx2 descendents
were reported to be indispensable for late AV cushion for-
mation and AV valve remodelling [38].
Discussion
Previous studies have demonstrated that Msx1 and Msx2
are both expressed in the AV endocardium, while Msx2 is
also expressed in the cushion mesenchyme and AV myo-
cardium [17,33,61,62]. In this study, we demonstrated
overlapping expression of Msx1 and Msx2 in not only the
AV endocardium but also the cushion mesenchyme (Fig.
2). In support of the overlapping expression patterns,
Msx1 and Msx2 exhibited redundant functions in the AV
endocardium and cushion mesenchyme during EMT. We
found that Msx1 and Msx2 function redundantly to upreg-
ulate  NFATc1  expression in the AV endocardium and
maintain Notch1 and Bmp2/4 expression in the AV cush-
ions during EMT (Fig. 3A–D and Fig. 5). Previous studies
demonstrated that NFATc1 signaling during valve mor-
phogenesis is dispensable for EMT (between E8.5 and
E10.5) but is required for remodeling of the endocardial
cushions into mature valve leaflets (after E11)
[9,10,12,63]. NFATc1 was found to regulate valve remod-
eling by transcriptional activation of matrix degrading
enzymes including cathepsin K, whose substrates are col-
lagen and elastin, via the RANKL signaling pathway [63].
Notch signaling in the AV endocardium was reported to
promote loss of cell-cell contact via down-regulation of
endocardial VE-cadherin and induce EMT via upregulation
of myocardial TGF-β2 [4,22]. To initiate EMT, Bmp2 acts
synergistically with TGF-βs to enhance the TGF-β-induced
phenotypic changes associated with EMT [16,18,19,40].
We failed to detect any significant change of expression of
Twist1, which has been implicated in down-regulation of
E-cadherin and VE-cadherin during epithelial- or endothe-
lial-to-mesenchymal transition [17,64,65]. It is likely that
the expression levels of other transcription factors which
also repress E-cadherin/VE-cadherin expression, including
Snail and Slug [4,64], are decreased in the Msx1-/-; Msx2-/
- mutant AV endocardium. In fact, Snail expression is acti-
vated by Notch signaling [22]. It remains to be deter-
mined whether the expression of Snail and VE-cadherin are
perturbed in the Msx1/2 double mutant AV endocardium.
In agreement with impaired EMT, we observed signifi-
cantly decreased total numbers of mesenchymal cells in
the Msx1-/-; Msx2-/- mutant AV cushions (Fig. 4I). Further-
more, only a small proportion of mesenchymal cells in
the Msx1/2 double mutant AV cushions expressed α-SMA,
suggesting impaired differentiation during EMT (Fig. 4D
and 4H). On the other hand, both cell proliferation and
cell survival were normal in Msx1-/-; Msx2-/- mutant AV
cushions during EMT (Fig. 4A, B, E, F and data not
shown).
Interestingly, we found decreased Bmp2/4 signaling and
expression of Tbx2,  Hand1  and  Hand2  in the Msx1-/-;
Msx2-/- mutant myocardium, including the AV myocar-
dium, which expresses Msx2 but not Msx1 in wild-type
embryos, and the chamber myocardium, where neither
Msx1 nor Msx2 is normally expressed. One possible expla-
nation is that perturbed gene expression in the double
mutant myocardium is a secondary effect of hemody-
namic changes due to the absence of normal AV cushions.
Reduced expression of both Hand1  and  Hand2  in the
Msx1/2  null mutant myocardium further supports our
previous hypothesis that Hand1 and Hand2 are candidate
target genes regulated by Msx1 and Msx2 [32]. Decreased
Hand1 expression in the Msx1/2 double mutant AV myo-
cardium may be associated with defects in remodeling of
the AV cushions into mature valve leaflets, since myocar-
dium-specific Hand1 deficiency led to thickened AV valves
[45], which were previously shown to be associated with
impaired valve remodeling [1,6,15].
It is noteworthy that, in contrary to decreased Bmp2/4 sig-
naling in the Msx1/2 null mutant AVC and chamber myo-
cardium, our previous study demonstrated increasedBMC Developmental Biology 2008, 8:75 http://www.biomedcentral.com/1471-213X/8/75
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Normal proliferation but decreased total cell numbers in Msx1-/-; Msx2-/- mutant AV cushions during EMT Figure 4
Normal proliferation but decreased total cell numbers in Msx1-/-; Msx2-/- mutant AV cushions during EMT. 
Immunostaining with the anti-BrdU antibody at both E11.5 and E12.5 revealed comparable levels of cell proliferation in the AV 
cushions and atrial and ventricular myocardium of Msx1-/-; Msx2-/- mutants and their littermate controls (compare A with B 
and E with F). Immunostaining against α-smooth muscle actin (α-SMA) showed dramatically reduced numbers of α-SMA-posi-
tive mesenchymal cells in the Msx1/2 null mutant AV cushions compared with the control (red arrows in D and H indicate 
sparse α-SMA-positive cells in the double mutant AV cushions). White asterisks in A, B, E and F, and red asterisks in C, D, G 
and H indicate the location of the AV cushions. I, Statistical analyses revealed significantly reduced total cell numbers in the AV 
cushions of the Msx1/2 double mutants compared with those of their littermate controls (at least 4 sections were counted for 
each embryo, and 3 pairs of Msx1/2 double mutants and their littermate controls were analysed; P < 0.01 for both E10.5 and 
E11.5, Student's t test). IVS, interventricular septum; LA and LV, left atrium and ventricle; RA and RV, right atrium and ventri-
cle. Scale bars: 0.1 mm in A (for A, B), C (for C, D), F (for E, F) and H (for G, H).BMC Developmental Biology 2008, 8:75 http://www.biomedcentral.com/1471-213X/8/75
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Bmp2/4 signaling in the double mutant OFT myocardium
and cushion mesenchyme [32]. It has been shown that
Bmp2 expression is normally switched from the OFT myo-
cardium to the AVC and atrial myocardium between E9.5
and E10.5 [16,61,66], suggesting that an alternative expla-
nation for perturbed Bmp signaling in Msx1-/-; Msx2-/-
mutant hearts is that Bmp2 expression does not shift from
the OFT to the AVC in the double mutants. Locally
reduced Bmp2 expression in the Msx1/2 null mutant AVC
may be insufficient to maintain normal expression of
Tbx2 and in turn lead to reduced Tbx2 and increased Anf
expression in the double mutant AV myocardium (Fig.
6A–D) [17,40,42,43,49]. Perturbed Bmp2 expression may
also disrupt normal Pitx2 expression in the Msx1-/-; Msx2-
/- mutant AVC and atrial myocardium, as Bmp2 has been
shown to be a positive regulator of Nodal signaling and
Pitx2 [67]. In addition, there may be altered expression
patterns of other Bmp molecules, including Bmp6, that
contribute to the abnormal distribution of Bmp signals in
the Msx1-/-; Msx2-/- mutant OFT and AV cushions. Inter-
estingly, Bmp6 exhibits an asymmetric (left-sided) expres-
sion in the OFT myocardium at E10.5, reminiscent of the
expression pattern of Pitx2 [53]. Bmp6 expression under-
goes a transition from the AV cushion mesenchyme to the
OFT cushion mesenchyme between E10.5 and E12.5,
indicating that it plays a critical role in both the EMT of
the AV cushions and the development of the OFT cush-
ions [16,53]. Further analyses of the expression patterns
of the aforementioned Bmp ligands will determine which
Bmp molecules are critical contributors to the impaired
development of the Msx1-/-; Msx2-/- mutant OFT and AV
cushions.
Conclusion
In this study, we documented redundant functions of
Msx1 and Msx2 genes in distinct aspects during AV cush-
ion morphogenesis: endocardial activation prior to EMT
(via upregulation of NFATc1  expression), induction of
EMT (via upregulation of Notch1 and Bmp2/4 signaling
in the AVC), as well as post-EMT valve remodelling (via
upregulation of Hand1  expression in the AV myocar-
dium).
Methods
Mouse strains and genotyping
All mice used in this study were maintained in a mixed
genetic background of BALB/c and CD-1. Msx1-/-  and
Msx2-/-  single knockout and Msx1-/-; Msx2-/- double
knockout mice were described previously [30,34,35]. The
noon copulation plug was counted as embryonic day 0.5
(E0.5). Genomic DNA was extracted from yolk sac
(embryos) or tails (postnatal mice) for genotyping. PCR
primers and conditions for Msx1 and Msx2 knockout alle-
les as well as the Wnt1-Cre and R26R transgenes were as
described [34,35,68].
Histology, section in situ hybridization and 
immunostaining
For histology, embryos at E15.5 were fixed with 4% para-
formaldehyde (PFA) in phosphate-buffered saline (PBS)
for 14 hours at 4°C, dehydrated through graded ethanol
and embedded in paraffin wax. Sections were cut at 7–8
μm and stained with Hematoxylin and Eosin. For cryostat
sectioning, fixed embryos at E10.5 were dehydrated
through graded methanol and stored in 100% methanol
at -20°C till use. Stored embryos were rehydrated through
graded methanol, washed in PBS, and cryopreserved in
sucrose solutions with increasing concentrations, then
frozen in O.C.T Sections were cut at 10-μm thickness and
RNA section in situ hybridization was performed using
the In Situ Hybridization kit (BioChain) with the protocol
modified according to Dijkman et al. [69]. All RNA probes
were generated as described: Anf [17], Hand1 [45], Hand2
[45], Has2 [17], Notch1 [17], Pitx2 [38], and Tbx2 [17].
For immunostaining, the following primary antibodies
were used: biotinylated goat polyclonal anti-BMP-2/4
(1:100, R&D Systems), mouse monoclonal anti-bromo-
deoxyuridine (BrdU) (1:100, Sigma), mouse monoclonal
anti-NFATc1 (1:200, BD Pharmingen; a kind gift from Dr.
Kaartinen), guinea pig polyclonal anti-Pitx2 (1:200, a
kind gift from Dr. Kioussi [70]), rabbit polyclonal anti-
phospho-Smad1/5/8 (1:50, Cell Signaling).
Littermates of each Msx1-/-; Msx2-/- mutant embryo were
used as the controls, and no discernable variation in either
gene expression or cell proliferation/survival/differentia-
tion was detected between the controls from the same lit-
ter and with different genotypes.
Abbreviations
Anf: Atrial natriuretic factor; AV: Atrioventricular; Bmp:
Bone morphogenetic protein; EMT: Endothelial-mesen-
chymal transformation; NFAT: Nuclear factor in activated
T cells; PBS: Phosphate-buffered saline; PFA: Paraformal-
dehyde; TGF: Transforming growth factor.
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Reduced Bmp2/4 signaling in Msx1-/-; Msx2-/- mutant AV cushions and myocardium during EMT Figure 5
Reduced Bmp2/4 signaling in Msx1-/-; Msx2-/- mutant AV cushions and myocardium during EMT. Panels E-H and 
M-P are enlarged views of the boxes in panels A-D (at E10.5) and I-L (at E11.5), respectively. Immunostaining for Bmp2/4 
(green fluorescence in A, B, E, F, I, J, M and N) and phosphorylated Smad1/5/8 (red fluorescence in C, D, G, H, K, L, O and P) 
revealed dramatically reduced Bmp2/4-positive and phospho-Smad-positive signals in the Msx1/2 mutant AV cushion mesen-
chyme (red asterisks in B, F, J, N and yellow asterisks in D, H, L, P) and myocardium (white triangle arrowheads in B, D, J and 
L) compared with the control (A, C, E, G, I, K, M and O). On the other hand, Msx1-/-; Msx2-/- mutants exhibit broader expres-
sion patterns of both Bmp2/4 and Smad1/5/8 in the pharyngeal mesoderm compared with controls (indicated by white arrows 
in A-D). Q and R indicate average percentages of Bmp2/4-positive and phospho-Smad1/5/8-positive cells in the control and 
Msx1/2 mutant AV cushions at E10.5 and E11.5 (n = 3 for each developmental stage, P < 0.001, Student's t test). LA and LV, left 
atrium and ventricle; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in A (for A-D), F (for E-H), I (for I-L) and N (for 
M-P).BMC Developmental Biology 2008, 8:75 http://www.biomedcentral.com/1471-213X/8/75
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Perturbed expression of chamber-specific genes in Msx1-/-; Msx2-/- mutant myocardium Figure 6
Perturbed expression of chamber-specific genes in Msx1-/-; Msx2-/- mutant myocardium. RNA section in situ 
hybridization at E10.5 demonstrated that Tbx2 expression was dramatically reduced in the Msx1/2 null mutant AV myocardium 
compared with the littermate control (compare the staining intensity in the regions pointed by red notched arrowheads in A 
and B). In contrast, the level of Tbx expression in the pharyngeal mesoderm was comparable between the control and the 
Msx1/2 double mutant (indicated by black arrows in A and B). Concomitant with decreased Tbx2 expression in the Msx1-/-; 
Msx2-/- mutant AV myocardium, Anf expression exhibited increased expression in the Msx1/2 double mutant AV myocardium 
(compare the staining intensity in the regions pointed by red notched arrowheads in C and D). In addition, we detected ectopic 
Anf expression in the double mutant right ventricle (red asterisk in D), which was likely a hemodynamic effect secondary to the 
changes of gene expression in the AV canal. Msx1/2 null mutants also exhibited decreased expression of Hand1 (F) and Hand2 
(H) in the AV myocardium (red notched arrowheads). In the Msx1/2 mutant AV myocardium, Hand1 expression was almost 
undetectable and Hand2 expression was significantly reduced compared with the control (red notched arrowheads in E-H). LA 
and LV, left atrium and ventricle; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in A (for A-D) and E (for E-H).BMC Developmental Biology 2008, 8:75 http://www.biomedcentral.com/1471-213X/8/75
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Decreased contribution of Pitx2-positive cells to the Msx1-/-; Msx2-/- mutant AV cushion mesenchyme Figure 7
Decreased contribution of Pitx2-positive cells to the Msx1-/-; Msx2-/- mutant AV cushion mesenchyme. Panels 
C, D, G and H are enlarged views of the boxes in A, B (at E10.5) and E, F (at E11.5), respectively. Pitx2 immunostaining (green 
fluorescence) revealed a substantial reduction in the number of Pitx2-positive cells in the Msx1-/-; Msx2-/- mutant AV cushion 
mesenchyme compared with the control (compare the regions marked by yellow asterisks in C, D, G and H). White notched 
arrowheads in D and H indicate sparse Pitx2-positive mesenchymal cells in the Msx1/2 null mutant AV cushions. There was no 
detectable Pitx2 expression in the left atrial myocardium of the Msx1/2 double mutants shown in B and F (indicated by white 
arrows). I, Statistical analyses revealed significantly reduced percentages of Pitx2-positive cells in the AV cushion mesenchyme 
of the Msx1/2 double mutants at both E10.5 and E11.5 (n = 3 for each developmental stage, P < 0.01 at E10.5, P < 0.001 at 
E11.5, Student's t test). LA and LV, left atrium and ventricle; RA and RV, right atrium and ventricle. Scale bars: 0.1 mm in B (for 
A, B) and F (for E, F), 0.05 mm in D (for C, D) and H (for G, H).BMC Developmental Biology 2008, 8:75 http://www.biomedcentral.com/1471-213X/8/75
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